Team

Dr Nusrat J M Sanghamitra

Founder, CEO / CSO

Connect :

Dr Nusrat Sanghamitra is an Indian innovator, scientist, entrepreneur and motivator. She started her research journey with a mission 'to find a better anticancer drug with fewer side effects'. She is a chemist by training with a fascination for biology. She obtained her PhD from one of India's premier research Institute Indian Institute of Science, Bangalore. After a Postdoctoral Fellowship in Leiden University, The Netherlands and Kyoto University, Japan she founded CyCa OncoSolutions (now CyGenica) to translate her ideas and research (at the interface of chemistry, biomaterials, cell biology and its applications in anticancer drug development) from bench to bedside, to make an impact in oncology and to make significant contribution to the global fight against cancer. Her academic experience in the field of biofunctional chemistry spans over 17 years. Her research has been well cited. She received the Foresight Fellowship in Molecular Machines in 2018, and the National Award from the President of India for Technology Startup that same year.

Dr Sk Fazlul Haque Krishnan

Director-Operations

Connect :

As Director- Operations Sk Fazlul Haque Krishnan has responsibility to ensure the execution of key policies, strategies and milestones of the company. He oversees operations management across the company’s research and development portfolio. Since joining CyGenica, Fazlul has been a key contributor in developing the operational plan of the company. Fazlul brings 15 years of expertise in managing high value funds and implementing health policies in various national and international organizations like Nutrition International, Save the Children, Digital Green and UNICEF to develop different program policies in healthcare management. Fazlul has completed MBA in health care management from IIHMR university.

Dr Nusrat J M Sanghamitra

Founder, CEO & CSO, Member, Board

Connect :

Dr Nusrat Sanghamitra is an Indian innovator, scientist, entrepreneur and motivator. She started her research journey with a mission 'to find a better anticancer drug with fewer side effects'. She is a chemist by training with a fascination for biology. She obtained her PhD from one of India's premier research institutes Indian Institute of Science, Bangalore. After a Postdoctoral Fellowship in Leiden University, The Netherlands and Kyoto University, Japan she founded CyCa OncoSolutions (now CyGenica) to translate her ideas and research (at the interface of chemistry, biomaterials, cell biology and its applications in anticancer drug development) from bench to bedside, to make an impact in oncology and to make significant contribution to the global fight against cancer. Her academic experience in the field of biofunctional chemistry spans over 17 years. Her research has been well cited. She received the Foresight Fellowship in Molecular Machines in 2018, and the National Award from the President of India for Technology Startup that same year.

Bill Liao

Chairman, Board

Connect :

Bill Liao is a Chinese-Australian-Irish entrepreneur, investor, former diplomat, business mentor, author, passionate leader and speaker, with a distinguished record in business development and community activism. Co-founder of the CoderDojo movement and of Weforest, his career in tech and business encompasses two unicorn companies and launching the world’s first bio-tech accelerator, RebelBio. He is a general partner of SOSV, a $750m venture capital fund and founder of the upcoming SOSV Momentum Pre-accelerator program.

Sir Prof. Fraser Stoddart

Member, Advisory Board (Science)

Connect :

Fraser Stoddart, 2016 Nobel Laureate in Chemistry, was born in Edinburgh, Scotland, in 1942. He obtained all his degrees from Edinburgh University and spent time at Queen’s University, Imperial Chemical Industries and the Universities of Sheffield and Birmingham in the UK before moving to UCLA in the US in 1997. He has mentored 450 undergraduate and graduate students and postdoctoral fellows during his career, has over 1150 publications, and has launched two startup companies. Stoddart was honored by Her Majesty Queen Elizabeth II as a Knight-Bachelor in her 2007 New Year’s Honors List for his services to chemistry and molecular nanotechnology.

Dr Satya Prakash Dash

Member, Board

Connect :

Dr Satya Prakash Dash is a technology and strategy leader who has contributed over the last decade to build and nurture a vibrant biotech and medtech innovation ecosystem in India. Currently he is heading the Global AMR R&D hub. He was also founding Head of Strategy, Partnerships & Entrepreneurship Development at BIRAC- the nodal biotech innovation agency in India where he conceptualised, designed & implemented 15 national programs & international partnerships including India’s largest early stage biotech/medtech funding BIG, social innovation program SPARSH/SIIP, incubator program BioNEST, sustainable development (SoCH), equity programs such as BIRAC-SEED & BIRAC AcE and partnerships with Longitude Prize (on AMR) and WISH Foundation (for clinical validation in the field). Cumulatively the programs have funded more than 1500 startups and innovators. He was the Director of Global Innovations at PATH, COO of ABLE (India’s nodal biotech industry organisation) and Consultant to IIM-Bangalore and Nesta UK. He is Member, Board of NCL-Venture Center, Pune- India’s largest S&T innovation incubator. Dr Dash actively advises technology startups from across the world. Dr Dash holds triple masters from the universities of Cambridge UK, Leicester UK and Sambalpur Odisha India and a PhD from University of East Anglia Norwich UK and is a British Chevening Scholar (1998).

David Rowan

Member, Board

David Rowan is an early-stage investor in more than 80 tech companies, runs a health-tech and a climate-tech fund, and advises VC funds including Lakestar and Outsized Ventures. He was founding Editor-in-chief of WIRED’s UK edition (2008-17), spent 10 years as an editor at The Guardian and trained as a journalist at The Times, and has been a technology columnist for The Times, GQ, Condé Nast Traveller and The Sunday Times. He's author of “Non-Bullshit Innovation” (Penguin, 2019), a 20-country quest for bold corporate innovation in the face of technology-led disruption. He's given more than 600 keynotes and often moderates conferences. David also runs a not-for-profit project called VOYAGERS.io that builds peer support among people working on impact-led projects, particularly in climate-tech and health-tech.

Sami Mikati

Observer, Board

Sami is an experienced corporate executive and angel investor in early stage life science startups. Sami brings a network and proactive commercial approach to early stage challenges.

Dr. Eion Fleming

Advisor
(Protein Engineering)

Dr. Eoin (J.V) Fleming graduated with a BSc. In Biochemistry from University College Cork,and a PhD in Molecular and Cellular Biology from the University of Aberdeen in Scotland. He completed a short industrially-funded project with Rowett Research Services in Aberdeen before moving to the US in 1997 where he worked initially as a postdoc at Massachusetts General Hospital, and then subsequently as a research assistant professor at the University of Massachusetts in Worchester. He returned to Europe in 2003 to work as a Senior Scientist at the Institute of Molecular Medicine in the University of Lisbon, before moving to University College Cork as a Lecturer in Biochemistry and Cell Biology in 2006. His primary research interest is in the cellular unfolded protein stress response, and he currently supervises four PhD students in his lab working on this topic. He additionally supervises a PhD student that is funded by Cygenica to explore the cellular properties and function of Geenie.

Professor Jason Davis

Member, Advisory Board
(Science)

Professor Jason Davisis a Professor of Chemistry and Fellow of Christ Church, Oxford. He studied Chemistry at Kings College London, where he was awarded The Victor Gold, Ivor John and Robert Wakeford Memorial Prizes in Chemistry and a First Class honours degree in 1993. He then undertook a DPhil in Chemistry at Oxford (1994-1998) he was elected to an Extraordinary Junior Research Fellowship at The Queens College in 1998, a Royal Society University Research Fellowship in 1999,a University Lectureship in 2003, a University Readershipin 2008 and Full Professorship in 2014. He has been A Dr Lee’s Reader and Senior Subject Tutor in Chemistry at Christ Church since 2006. His research is primarily focussed on the design/utilisation of advanced functional interfaces, particularly those associated with Diagnostics, Sensing, Molecular Switches and Responsive Imaging, where his group have published more than 170 primary papers. He has extensive experience of multidisciplinary and translational research, a significant IP portfolio, and is the academic founder of Osler Diagnostics in Oxford.